Hypertension Pipeline Analysis of Companies and Drug Profile Market Report H1 2017


Posted June 19, 2017 by justinebiel

The pipeline guide reviews pipeline therapeutics for Hypertension (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.

 
The Hypertension Pipeline for Therapeutics Development in H1 2017 Market report provides comprehensive information on the therapeutics under development for Hypertension (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Hypertension pipeline guide also reviews of key players involved in therapeutic development for Hypertension and features dormant and discontinued projects.

Key players are A1M Pharma AB, Actelion Ltd, Alnylam Pharmaceuticals Inc, Anacor Pharmaceuticals Inc, AnGes MG Inc, Arena Pharmaceuticals Inc, Ascendis Pharma A/S, Asklepion Pharmaceuticals LLC, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc, Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp, CJ HealthCare Corp, Conatus Pharmaceuticals Inc, Corion Biotech Srl, Cumberland Pharmaceuticals Inc, Cytokinetics Inc, Daewoong Co Ltd, Daewoong Pharmaceutical Co Ltd, Daiichi Sankyo Company Ltd, DiaMedica Therapeutics Inc, Eli Lilly and Company, Esperion Therapeutics Inc, F. Hoffmann-La Roche Ltd

The guide covers Hypertension therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 7, 1 and 2 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.

Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1057922 .

Hypertension (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1057922

Scope
• The pipeline guide provides a snapshot of the global therapeutic landscape of Hypertension (Cardiovascular).
• The pipeline guide reviews pipeline therapeutics for Hypertension (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Hypertension (Cardiovascular) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Hypertension (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Hypertension (Cardiovascular)

Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1057922

List of Figures
Number of Products under Development for Hypertension, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Top 10 Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017

About Us:
ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By justinebiel
Country India
Categories Health , Reports , Research
Tags hypertension , hypertension market , hypertension pipeline , hypertension report
Last Updated June 19, 2017